Journal
PATIENT PREFERENCE AND ADHERENCE
Volume 4, Issue -, Pages 355-362Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/PPA.S10620
Keywords
varenicline; tobacco dependence; smoking cessation; nicotine addiction
Categories
Ask authors/readers for more resources
Smoking is the leading preventable cause of morbidity and mortality in the US, and decreasing smoking prevalence is a public health priority. Patients achieve the greatest success when quit attempts involve behavioral therapy combined with pharmacotherapy. Varenicline is the most recent addition to the pharmacotherapeutic armamentarium for the treatment of tobacco dependence. Varenicline is efficacious and cost-effective. Smoking relapse and adverse treatment-related side effects may decrease medication adherence and patient satisfaction with varenicline. In the clinical setting, varenicline treatment can be optimized by reducing doses in patients who experience intolerable side effects, increasing the dose in partial responders, and providing long-term maintenance therapy for relapse prevention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available